Corticosteroid versus Ozone Injections in Chronic Plantar Fasciitis: A Comparative Clinical Study
Abstract
Objective: Plantar fasciitis is a common degenerative condition causing chronic heel pain and functional limitation. Corticosteroid injections are widely used but carry potential adverse effects, whereas ozone therapy has emerged as an alternative with anti-inflammatory and regenerative properties.The aim of this study is to compare the efficacy of ultrasound-guided corticosteroid and ozone injections on pain, function, and quality of life in chronic plantar fasciitis.
Methods: This retrospective cohort study included 59 patients unresponsive to conservative treatment. Patients received either a single corticosteroid injection (Group S, n=30) or three weekly ozone injections (Group O, n=29). Outcomes were assessed using the Numerical Rating Scale (NRS), Foot Function Index (FFI), and Short Form-12 (SF-12) at baseline, 1 month, and 3 months. Treatment response was defined as ≥50% reduction in NRS.
Results: Both groups showed significant improvement over time (p<0.001). Pain reduction was similar at 1 month. At 3 months, corticosteroids resulted in lower NRS scores (p=0.024) and higher responder rates (70.0% vs. 31.0%, p=0.003). Corticosteroids provided greater short-term functional improvement, whereas ozone showed superior FFI scores at 3 months (p<0.001). SF-12 physical scores improved similarly; mental scores favored corticosteroids (p=0.025). No serious adverse events occurred.
Conclusions: Both injections effectively improve pain, function, and quality of life in plantar fasciitis. Corticosteroids provide superior pain relief, while ozone may offer better long-term functional improvement. Treatment selection should be individualized based on clinical priorities.
Keywords
Project Number
Ethical Statement
References
- Lemont H, Ammirati KM, Usen N. Plantar fasciitis: a degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc. 2003 May-Jun;93(3):234-7. doi:10.7547/87507315-93-3-234.
- Liebmann K, Kimbrough DW, Best TM, Kouroupis D, Rodriguez Materon S. Plantar Fasciitis Pathophysiology and the Potential Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles as Therapy. Biomedicines. 2025 Jun 23;13(7):1528. doi:10.3390/biomedicines13071528.
- Nahin RL. Prevalence and Pharmaceutical Treatment of Plantar Fasciitis in United States Adults. J Pain. 2018 Aug;19(8):885-96. doi:10.1016/j.jpain.2018.03.003.
- Hansen L, Krogh TP, Ellingsen T, Bolvig L, Fredberg U. Long-Term Prognosis of Plantar Fasciitis: A 5- to 15-Year Follow-up Study of 174 Patients With Ultrasound Examination. Orthop J Sports Med. 2018 Mar 6;6(3):2325967118757983. doi:10.1177/2325967118757983.
- Tseng WC, Chen YC, Lee TM, Chen WS. Plantar Fasciitis: An Updated Review. J Med Ultrasound. 2023 Oct 6;31(4):268-74. doi:10.4103/jmu.jmu_2_23.
- Goff JD, Crawford R. Diagnosis and treatment of plantar fasciitis. Am Fam Physician. 2011 Sep 15;84(6):676-82.
- Thomas JL, Christensen JC, Kravitz SR, Mendicino RW, Schuberth JM, Vanore JV, et al. The diagnosis and treatment of heel pain: a clinical practice guideline-revision 2010. J Foot Ankle Surg. 2010 May-Jun;49(3 Suppl):S1-19. doi:10.1053/j.jfas.2010.01.001.
- Guimarães JS, Arcanjo FL, Leporace G, Metsavaht LF, Conceição CS, Moreno MVMG, et al. Effects of therapeutic interventions on pain due to plantar fasciitis: a systematic review and meta-analysis. Clin Rehabil. 2023 Jun;37(6):727-46. doi:10.1177/02692155221143865.
Details
Primary Language
English
Subjects
Pain
Journal Section
Research Article
Early Pub Date
August 25, 2026
Publication Date
-
Submission Date
May 4, 2026
Acceptance Date
June 12, 2026
Published in Issue
Year 2026 Number: Advanced Online Publication